Weight loss drug windfall attracts pharma companies

Source: Reuters SAN FRANCISCO, Jan 11 (Reuters) – Pharmaceutical executives from Amgen (AMGN.O) to Pfizer (PFE.N) are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk’s (NOVOb.CO) Wegovy and Zepbound from Eli Lilly (LLY.N). At stake is a market that is now estimated to reach $100 billion at […]